Financials
Financial year 2025
PHARMACIE HOUBA from Brussel, company number BE0891466622, closed financial year 2025 with a result of € 1.5 million after tax. For that financial year PHARMACIE HOUBA recorded revenue of € 21.2 million and equity of € 4.3 million. Compared with financial year 2024, the result moved from € 1.3 million to € 1.5 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 23, 2026.
€ 4.3 million
▲ 52% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 1.5 million
▲ 14% vs 2024
Profit after tax over the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 4.3 million.
People and assets in 2025
39.8
▼ 1.4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 1.9 million
▲ 7% vs 2024
€ 48,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 1,537
▼ 65% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 4,674
€ 2,542 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 4 million
▼ 6% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 84 days on average.
€ 459,794
▼ 6% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | € 19,185,434 | € 20,960,037 | € 21,205,907 | ▲ 1% |
| Gross margin | € 1,793,477 | € 2,909,218 | - | - | |
| Profit after taxes | € 177,616 | € 848,063 | € 1,293,354 | € 1,469,818 | ▲ 14% |
| Equity | € 672,793 | € 1,520,856 | € 2,814,210 | € 4,284,028 | ▲ 52% |
| Total debts | € 6,236,787 | € 6,733,712 | € 4,730,998 | € 4,465,775 | ▼ 6% |
| Cash | € 733,506 | € 5,531 | - | - | |
| Retained profit | € 654,193 | € 1,502,256 | € 2,795,610 | € 4,265,428 | ▲ 53% |
| Bank debt | € 315,683 | € 112,901 | € 4,674 | € 4,674 | |
| Balance sheet total | € 6,948,580 | € 8,293,569 | € 7,565,208 | € 8,749,802 | ▲ 16% |
| Employees (FTE) | 27.4 | 38 | 41.2 | 39.8 | ▼ 1.4 |
Key figures of PHARMACIE HOUBA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE HOUBA?
What happened at PHARMACIE HOUBA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 1.5 million (▲ 14% vs 2024). Source: NBB ↗
- Korian Belgium NV became a director. NBB
- SL Finance NV became a director. NBB
- New establishment in Nivelles. KBO
- Start of the company according to the CBE. KBO
- New establishment in Brussel. KBO
In short
From € 177,616 profit in 2022 to € 1.5 million profit in 2025.
Paid € 1.2 million in corporate taxes since 2022.
Best year ever: 2025, with € 1.5 million profit.
On average € 76,600 of value added per employee in 2023.
A new publication or filing at PHARMACIE HOUBA? We notify you, reason included.
Follow PHARMACIE HOUBADatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMACIE HOUBA are Korian Belgium NV and SL Finance NV. The shares are held by Korian Belgium NV (100%).
Directors
According to the 2025 annual accounts
Managing director · represented by Dominiek Beelen
Also active at: FEDERATIE DER RUSTOORDEN VAN BELGIE (MR-MRS) - FEDERATION DES MAISONS DE REPOS PRIVEES DE BELGIQUE, Senior Living Group Vlaanderen, Résidence 3, HOME INGENDAEL, Nouvelle Résidence Le Saule, Ten Prins, Home Eksterveld, VALDAMI +84 more
since 2022
Director · represented by Liesbet Danneels
Also active at: Senior Living Group Vlaanderen, Résidence 3, HOME INGENDAEL, Nouvelle Résidence Le Saule, Ten Prins, Home Eksterveld, VALDAMI, Home Résidence du Plateau +80 more
since 2022
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Houba de Strooperlaan 92
1020 Brussel
Chemin de la Vieille-Cour 57
1400 Nivelles
Active since 1 March 2016
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0891.466.622
- VAT number
- BE 0891.466.622
- Registered office
- Houba de Strooperlaan 92, 1020 Brussel
- Names & denominations
- PHARMACIE HOUBA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 17 August 2007
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers